📰 Cingulate Inc News
Page 5 - Cingulate Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cingulate Inc. Real-time updates on events, politics, business and more.
October 11, 2023
PRISM MarketView Launches Mental Health Index on World Mental Health ...
September 30, 2023
Cingulate Inc. (NASDAQ:CING – Get Free Report) was the recipient of a large decrease in short interest in the month of September. As of September 15th, there was short interest totalling 523,700 shares, a decrease of 32.4% from the August 31st total of 774,300 shares. Based on an average trading volume of 527,200 shares, the […]
September 29, 2023
Cingulate (NASDAQ:CING – Free Report) had its target price trimmed by HC Wainwright from $5.50 to $3.50 in a research report released on Tuesday morning, Marketbeat reports. The brokerage currently has a buy rating on the stock. HC Wainwright also issued estimates for Cingulate’s Q3 2023 earnings at ($0.24) EPS, Q4 2023 earnings at ($0.13) […]
September 21, 2023
Kansas City, Kansas--(Newsfile Corp. - September 21, 2023) - Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its
September 21, 2023
KANSAS CITY, Kan., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology
September 19, 2023
The Dow Jones closed slightly higher on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
September 18, 2023
Cingulate Inc. (NASDAQ:CING – Get Free Report) was the target of a large growth in short interest in August. As of August 31st, there was short interest totalling 774,300 shares, a growth of 22.5% from the August 15th total of 632,000 shares. Currently, 9.3% of the company’s stock are sold short. Based on an average […]
September 12, 2023
Gainers AgileThought, Inc. (NASDAQ: AGIL) shares rose 72.5% to $0.2160 in pre-market trading after declining 12% on Monday.
September 11, 2023
KANSAS CITY, Kan., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING) (“Cingulate,” the “Company,” “we,” “our” or “us”), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™)